A three-dimensional model of the Fas/APO-1 molecule: Cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites

International Immunology

Volumn 10, Issue 2, 1998, Pages 131-140

  Fadeel, Bengt ^a,b   Lindberg, Jakob ^a   Achour, Adnane ^a   Chiodi, Francesca ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Epitope mapping; Fas APO 1; Homology based modeling; Nerve growth factor receptor family; Structural mimicry; Tumor necrosis factor

Indexed keywords

ANTIBODY; EPITOPE; FAS ANTIGEN;

ANTIBODY COMBINING SITE; ARTICLE; CROSS REACTION; EPITOPE MAPPING; MOLECULAR MIMICRY; MOLECULAR MODEL; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; COMPUTER SIMULATION; CYSTEINE; EPITOPE MAPPING; FAS LIGAND PROTEIN; HUMANS; MACROMOLECULAR SUBSTANCES; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031884694     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.2.131     Document Type: Article

References (38)

1. Wyllie, A. H., Kerr, J. F. R. and Currie, A. R. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251.
2. Duvall, E. and Wylle,. H. 1986. Death and the cell. Immunol. Today 7:115.
3. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 6:233.
4. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B. C., Ponsting, H. and Krammer, P. H. 1992. Purification and molecularcloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol Chem. 267:10709.
5. Suda, T., Takahashi, T., Golstein, P. and Nagata, S. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
6. Itoh, N. and Nagata, S. 1993. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem. 268:10932.
7. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
8. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
9. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. 1994. Generalized lympho-proliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
10. Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagata, H. and Okomura, K. 1994. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl Acad. Sci. USA 91:4930.
11. Debatin, K.-M., Fahrig-Faissner, A., Enenkel-Stoodt, S., Kreuz, W., Benner, A. and Krammer, P. H. 1994. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 3:3101.
12. Katsikis, P. D., Wunderlich, E. S., Smith, C. A., Herzenberg, L. A. and Herzenberg. L. A. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:2029.
13. Galle, P. R., Hofmann, W. J., Walczak, H, Schaller, H., Otto, G., Stremmel, W., Krammer, P. H. and Runkel, L. 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223.
14. Fadeel, B., Thorpe, C. J. and Chiodi, F. 1995. Mapping of the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb. Int. Immunol. 7:1967.
15. Fadeel, B., Thorpe, C. J., Yonehara, S. and Chiodi, F. 1997. Anti-Fas IgG1 antibodies recognizing the same epitopes of Fas/APO-1 mediate different biological effects in vitro. Int. Immunol. 9:201.
16. Huang. X, and Miller, W. 1991. A time-efficient, linear-space local similarity algorithm. Adv. Appl. Math. 12:337.
17. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H. and Lesslauer, W. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNF-β complex: implications for TNF receptor activation. Cell 73:431.
18. Sutcliffe, M. J., Haneef, I., Carney, D and Blundell, T. L. 1987. Knowledge based modeling of homologous proteins. 1. 3-dimensional frameworks derived from the simultaneous superposition of multiple structures. Protein Eng. 1:377.
19. Sutcliffe, M. J., Hayes, F. R. F. and Blundell, T. L. 1987. Knowledge based modeling of homologous proteins. 2. Rules for the conformations of substituted sidechains. Protein Eng. 1:385.
20. Weiner, S. J., Kollman, P. A., Nguyen, D. T. and Case, D. A. 1986. Force-field for simulation of proteins and nucleic acids. J. Comput. Chem. 7:230.
21. Houghten, R. A. 1985. General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl Acad. Sci. USA 82:5131.
22. Houghten, R. A., Bray, M. K., DeGraw, S. T. and Kirby, C. J. 1986. Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavages of protected peptide resins. Int. J. Peptide Protein Res. 27:673.
23. Marsters, S. A., Frutkin, A. D., Simpson, N. J., Fendly, B. M. and Ahkenazi, A. 1992. Identification of cysteine-rich domains of the type I tumor necrosis factor receptor involved in ligand binding. J. Biol. Chem. 267:5747.
24. Peitsch, M. C. and Jongeneel, C. V. 1993. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int. Immunol. 5:233.
25. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T. and Nagata, S. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567.
26. Eck, M. J. and Sprang, S. R. 1989. The structure of tumor necrosis factor-α at 2.6 Å resolution. J. Biol. Chem. 264:17595.
27. Karpusas, M., Hsu, Y. M., Wang, J. H., Thompson, J., Lederman, S., Chen, L. and Thomas, D. 1995. 2 Å crystal structure of an extracellular fragment of human CD40 ligand. Structure 3:1031.
28. Tanaka, M., Suda, T., Takahashi, T, and Nagata, S. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1129.
29. Yonehara, S., Ishii, A, and Yonehara, M. 1992. Receptor system of tumor necrosis factor: cell surface Fas antigen appears to mediate only the cytolytic activity of TNF. In Osawa, T, and Bonavida, B., eds, Tumor Necrosis Factor: Structure-Function Relationship and Clinical Application, p. 58. Basel, Karger.
30. Heldin, C.-H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80:213.
31. Starling, G. C., Bajorath, J., Emswiler, J., Ledbetter, J. A., Aruffo, A. and Kiener, P. A. 1997. Identification of amino acid residues important for ligand binding to Fas. J. Exp. Med. 185:1487.
32. Schneider, P., Bodmer, J.-L., Holler, N., Mattmann, C., Scuderi, P., Terskikh, A., Peitsch, M. C. and Tschopp, J. 1997. Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J. Biol. Chem. 272:18827.
33. Björling, E., Chiodi, F., Utter, G. and Norrby, E. 1994. Two neutralizing domains in the V3 region in the envelope glycoprotein gp 125 of HIV type 2. J. Immunol. 152:1952.
34. Dyson, H. J., Rance, M., Houghton, R. A., Lerner, R. A. and Wright, P. E. 1988. Folding of immunogenic peptide fragments of proteins in water solution. II The nascent helix. J. Mol. Biol. 201:161.
35. Åkerlind-Stopner, B., Utter, G., Mufson, M. A., Örvell, C., Lerner, R. A. and Norrby, E. 1990. A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop. J. Virol. 64:5143.
36. Naismith, J. H., Devine, T. Q., Brandhuber, B. J. and Sprang, S. R. 1995. Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J. Biol. Chem. 270:13303.
37. Evans, S. V. 1993. SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. J. Mol. Graphics 11:134.
38. Hahne, M., Peitsch, M. C., Irmler, M., Schröter, M., Lowin, B., Rousseau, M., Bron, C., Renno, T., French, L. and Tschopp, J. 1995. Characterization of the non-functional Fas ligand of gld mice. Int. Immunol. 7:1381.